Neuronetics, Inc.
STIM
$1.39
-$0.04-2.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 78.62% | 54.17% | 22.16% | 4.96% | 5.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.62% | 54.17% | 22.16% | 4.96% | 5.03% |
| Cost of Revenue | 304.36% | 177.12% | 78.70% | 13.45% | -19.08% |
| Gross Profit | 16.08% | 15.15% | 3.82% | 2.16% | 14.47% |
| SG&A Expenses | 26.34% | 22.81% | 16.24% | 4.42% | 0.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.97% | 50.54% | 29.08% | 8.85% | -4.61% |
| Operating Income | -45.45% | -40.76% | -48.88% | -18.54% | 24.32% |
| Income Before Tax | -22.48% | -49.51% | -76.25% | -44.84% | -10.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.48% | -49.51% | -76.25% | -44.84% | -10.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.18% | -50.27% | -76.13% | -44.78% | -10.03% |
| EBIT | -45.45% | -40.76% | -48.88% | -18.54% | 24.32% |
| EBITDA | -45.08% | -41.69% | -51.34% | -19.62% | 25.96% |
| EPS Basic | 31.26% | -3.68% | -39.07% | -30.60% | -3.71% |
| Normalized Basic EPS | 11.80% | -1.31% | -24.33% | -17.64% | 21.07% |
| EPS Diluted | 31.26% | -3.68% | -39.07% | -30.60% | -3.71% |
| Normalized Diluted EPS | 11.80% | -1.31% | -24.33% | -17.64% | 21.07% |
| Average Basic Shares Outstanding | 94.91% | 65.68% | 36.62% | 10.40% | 5.44% |
| Average Diluted Shares Outstanding | 94.91% | 65.68% | 36.62% | 10.40% | 5.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |